Professor Monceaux Named Inventor on Patent

Chris Monceaux, Associate Professor of Chemistry, was named as an inventor on a new patent entitled “Inhibiting Neurotransmitter Uptake.” The invention described by the patent was work carried out in conjunction with the Mayo Foundation and Virginia Tech, and it includes biologically active compounds which inhibit the re-uptake of the “big three” neurotransmitters: serotonin, norepinephrine, and dopamine in the brain. This invention seeks to increase the overall amount of neurotransmitters available in the brain, leading to a decrease in symptoms associated with depression, anxiety, addiction, and attention deficit hyperactivity disorder. The invention, which was originally filed with the United States Patent Office in 2014, has undergone a multi-year review process to assess its novelty and utility. This process culminated in the final issuance of a United States Patent earlier this year.


Aug 31, 2018
Department of Chemistry